Mocrane Abbar
Impact in
- Biological Psychiatry top 1%
- Tryptophan and brain disorders
- Psychiatry and Mental health top 2%
- Bipolar Disorder and Treatment
- Schizophrenia research and treatment
- Electroconvulsive Therapy Studies
- Psychosomatic Disorders and Their Treatments
Papers in ⓘ
-
- Tryptophan and brain disorders 8
-
- Bipolar Disorder and Treatment 11
- Schizophrenia research and treatment 8
- Attention Deficit Hyperactivity Disorder 5
- Psychosomatic Disorders and Their Treatments 5
- Co-authors
- Philippe Courtet (20 shared papers)Ludovic Samalin (10 shared papers)Pierre‐Michel Llorca (9 shared papers)Sébastien Guillaume (8 shared papers)Sylvie Lancrenon (6 shared papers)Guillaume Fond (5 shared papers)Fabrice Jollant (6 shared papers)Marion Leboyer (5 shared papers)
In The Last Decade
Mocrane Abbar
46 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 96
- Biological Psychiatry 363
- Psychiatry and Mental health 611
- Pharmacology 413
- Clinical Psychology 420
- Cellular and Molecular Neuroscience 326
Countries citing papers authored by Mocrane Abbar
This map shows the geographic impact of Mocrane Abbar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mocrane Abbar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mocrane Abbar more than expected).
Fields of papers citing papers by Mocrane Abbar
This network shows the impact of papers produced by Mocrane Abbar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mocrane Abbar. The network helps show where Mocrane Abbar may publish in the future.
Co-authors
The 25 scholars most cited alongside Mocrane Abbar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 247 | |
| 2 | 2001 | 142 | |
| 3 | 2013 | 140 | |
| 4 | Ketamine for the acute treatment of severe suicidal ideation: double blind, randomised placebo controlled trial Hit paper breakdown → | 2022 | 101 |
| 5 | 2001 | 72 | |
| 6 | 1995 | 61 | |
| 7 | 2019 | 46 | |
| 8 | 1998 | 39 | |
| 9 | 2011 | 37 | |
| 10 | 2018 | 33 | |
| 11 | 2014 | 32 | |
| 12 | 2015 | 31 | |
| 13 | 2016 | 29 | |
| 14 | 2002 | 28 | |
| 15 | 2010 | 26 | |
| 16 | 2012 | 24 | |
| 17 | 2015 | 23 | |
| 18 | 2023 | 23 | |
| 19 | 2022 | 22 | |
| 20 | 2017 | 20 |
About Mocrane Abbar
Mocrane Abbar is a scholar working on Biological Psychiatry, Psychiatry and Mental health, Clinical Psychology, Pharmacology and Behavioral Neuroscience, having authored 48 papers that have together received 1.4k indexed citations. Recurring topics across this work include Bipolar Disorder and Treatment (11 papers), Treatment of Major Depression (10 papers), Suicide and Self-Harm Studies (9 papers), Tryptophan and brain disorders (8 papers), Schizophrenia research and treatment (8 papers), Neurotransmitter Receptor Influence on Behavior (7 papers), Attention Deficit Hyperactivity Disorder (5 papers) and Psychosomatic Disorders and Their Treatments (5 papers). The work is most often cited by research in Biological Psychiatry (363 citations), Psychiatry and Mental health (611 citations), Pharmacology (413 citations), Clinical Psychology (420 citations) and Cellular and Molecular Neuroscience (326 citations). Mocrane Abbar has collaborated with scholars based in France, Spain and Canada. Frequent co-authors include Philippe Courtet, Ludovic Samalin, Pierre‐Michel Llorca, Sébastien Guillaume, Sylvie Lancrenon, Guillaume Fond, Fabrice Jollant, Marion Leboyer, Alain Malafosse and Catherine Burési. Their work appears in journals such as L Encéphale, Clinical Neuropharmacology, Journal of Affective Disorders, BMC Psychiatry and Psychopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.